The clinicopathological relevance for the expression of cyclin E, CDK2, and p27 in endometrial carcinoma. |
Yun Ji Baek, Hye In Chong, Ho Jin Jang, Dong Soo Suh, Man Soo Yoon, Kyung Un Choi |
1Department of Obstetrics & Gynecology, School of Medicine, Pusan National University Hospital, Busan, Korea. msyoon@pusan.ac.kr 2Department of Pathology, School of Medicine, Pusan National University Hospital, Busan, Korea. |
|
Abstract |
OBJECTIVE The aim of this study was to evaluate the clinicopathological relevance for the expression of cyclin E, CDK2 and p27 in endometrial carcinoma. METHODS: With a retrospective review, slide samples (n=71) were analyzed. All patients had been treated with hysterectomy from January 1998 to December 2006. The expression of cyclin E, CDK2 and p27 were analyzed using immunohistochemical staining. RESULTS: Of 71 cases, the positive expression was cyclin E; 28 cases (39.4%), CDK2; 29 cases (40.8%). The expression of cyclin E showed positive correlation with lymph node metastasis (P=0.033) and estrogen receptor. The expression of CDK2 showed positive correlation with estrogen receptor (P=0.000). The negative expression of p27 was 42 cases (59.2%) and showed no correlation with other clinicopathological factors. Cyclin E overexpression with loss of p27 expression showed positive correlation with advanced stage (P=0.002), lymphovascular invasion (P=0.030) and lymph node metastasis (P=0.002). CONCLUSION: Cyclin E overexpression with loss of p27 expression could be an useful negative prognostic factors for endometrial carcinoma. |
Key Words:
Cyclin E, CDK, p27, Endometrial carcinoma |
|